Market intelligence across pharma, MedTech, and digital health.
3,460+ published studies covering therapeutics, diagnostics, devices, and healthcare services — sized bottom-up and top-down, validated by our dedicated Healthcare & Medical Devices research team, and delivered with country-level detail.
The Healthcare & Medical Devices Research Team
This vertical is covered by a dedicated research group inside Fundamental Business Insights that tracks the global healthcare and medical technology industry full-time. Our analysts follow clinical adoption trends, regulatory developments, reimbursement policy, healthcare infrastructure investment, and evolving patient-care requirements as they happen — not just at the point a report is commissioned.
Every estimate in this vertical is built from primary conversations with healthcare stakeholders and cross-checked against company financial disclosures, regulatory publications, clinical literature, and government health databases, then reconciled through both bottom-up and top-down modeling before an internal quality review.
Who we interview
Clinical KOLs, regulatory affairs heads, hospital procurement leads, and MedTech product & commercial teams.
Regulatory fluency
Analysts track FDA, EMA, and regional approval pathways so device and drug forecasts reflect real timelines.
Reimbursement modeling
Forecasts factor in payer policy and reimbursement shifts, not just clinical or technology adoption curves.
Sub-domains we track
Healthcare & Medical Devices reports on this site span the following sub-domains. Reports aren't filed under these as separate sub-categories yet — search or browse the full list below to find a specific market.
Pharmaceuticals
Small-molecule and branded/generic drug markets across therapeutic areas and dosage forms.
Biotechnology & Advanced Therapies
Cell and gene therapies, biologics, and next-generation biotech platforms.
Medical Devices
Diagnostic, surgical, monitoring, and implantable device categories across care settings.
Medical Diagnostics
In-vitro diagnostics, imaging, and point-of-care testing markets.
Analytical & Laboratory Technologies
Lab instrumentation, reagents, and analytical platforms used in research and clinical settings.
Healthcare IT & Digital Health
EHR platforms, telehealth, remote monitoring, and clinical software markets.
Clinical & Healthcare Services
Hospital operations, outpatient care, and healthcare service delivery models.
Veterinary Healthcare
Animal health diagnostics, pharmaceuticals, and veterinary device markets.
Life Science Research Tools
Instruments, reagents, and platforms supporting pharmaceutical and academic research.
Secondary sources behind this vertical
Alongside primary interviews, every Healthcare & Medical Devices estimate is checked against these authoritative public and regulatory sources.
| Secondary source | Official website |
|---|---|
| World Health Organization (WHO) | who.int ↗ |
| U.S. Food & Drug Administration (FDA) | fda.gov ↗ |
| European Medicines Agency (EMA) | ema.europa.eu ↗ |
| Centers for Disease Control and Prevention (CDC) | cdc.gov ↗ |
| National Institutes of Health (NIH) | nih.gov ↗ |
| National Center for Biotechnology Information (NCBI) | ncbi.nlm.nih.gov ↗ |
| PubMed | pubmed.ncbi.nlm.nih.gov ↗ |
| ClinicalTrials.gov | clinicaltrials.gov ↗ |
| International Organization for Standardization (ISO) | iso.org ↗ |
| ASTM International | astm.org ↗ |
| Advanced Medical Technology Association (AdvaMed) | advamed.org ↗ |
| Medical Device Innovation Consortium (MDIC) | mdic.org ↗ |
| Biotechnology Innovation Organization (BIO) | bio.org ↗ |
| Int'l Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | ifpma.org ↗ |
| U.S. Pharmacopeia (USP) | usp.org ↗ |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | edqm.eu ↗ |
| World Organisation for Animal Health (WOAH) | woah.org ↗ |
| American Hospital Association (AHA) | aha.org ↗ |
| OECD Health | oecd.org/health ↗ |
| World Bank Data | data.worldbank.org ↗ |
Benzodiazepine Drugs Market Size & Growth Forecast 2027–2036, By Segments (Drug Class, Indication, Product, Route of Administration, Distribution Channel), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Benzodiazepine Drugs Market size is forecast to climb from USD 3 billion in 2025 to USD 4.48 billion by 2035, expanding at a CAGR of over 4.1% during 2026-2035. Industry revenue in...
Cell Counting Market Size & Growth Forecast 2027–2036, By Segments (End-user, Product Type, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Cell Counting Market size is likely to expand from USD 12.99 billion in 2025 to USD 24.85 billion by 2035, posting a CAGR above 6.7% across 2026-2035. The industry’s revenue potent...
Fibrate Drugs Market Size & Growth Forecast 2027–2036, By Segments (Product Type, Distribution Channel, Drug Type, Indication, End-Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Fibrate Drugs Market size is forecasted to reach USD 5.68 billion by 2035, rising from USD 3.39 billion in 2025, at a CAGR of more than 5.3% between 2026 and 2035. In 2026, revenue...
In-vitro Fertilization Microscope Market Size & Growth Forecast 2027–2036, By Segments (Product Type, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
In-vitro Fertilization Microscope Market size is forecasted to reach USD 314.18 million by 2035, rising from USD 136.42 million in 2025, at a CAGR of more than 8.7% between 2026 an...
Lipid Regulators Market Size & Growth Forecast 2027–2036, By Segments (Type, Route of Administration, Distribution Channel, Indication), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Lipid Regulators Market size is projected to grow steadily from USD 34.63 billion in 2025 to USD 51.26 billion by 2035, demonstrating a CAGR exceeding 4% through the forecast perio...
Neutropenia Treatment Market Size & Growth Forecast 2027–2036, By Segments (Drug Type, Route of Administration, Distribution Channel, Treatment Type, Indication), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Neutropenia Treatment Market size is projected to grow steadily from USD 15.57 billion in 2025 to USD 23.72 billion by 2035, demonstrating a CAGR exceeding 4.3% through the forecas...
Opioid Induced Constipation Drugs Market Size & Growth Forecast 2027–2036, By Segments (Distribution Channel, Prescription Type, Route of Administration, Drug Class), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Opioid Induced Constipation Drugs Market size is expected to advance from USD 2.28 billion in 2025 to USD 3.71 billion by 2035, registering a CAGR of more than 5% across 2026-2035....
Oral Transmucosal Drugs Market Size & Growth Forecast 2027–2036, By Segments (Route of Administration, Distribution Channel, Product Type, Indication), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Oral Transmucosal Drugs Market size is predicted to expand from USD 38.48 billion in 2025 to USD 74.29 billion by 2035, with growth underpinned by a CAGR above 6.8% between 2026 an...
Phoropter Market Size & Growth Forecast 2027–2036, By Segments (Product Type, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Phoropter Market size is likely to expand from USD 152.41 million in 2025 to USD 241.26 million by 2035, posting a CAGR above 4.7% across 2026-2035. The industry’s revenue potentia...
Pulmonary Fibrosis Biomarkers Market Size & Growth Forecast 2027–2036, By Segments (Test Type, End-user, Indication), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Pulmonary Fibrosis Biomarkers Market size is likely to expand from USD 4.43 billion in 2025 to USD 6.95 billion by 2035, posting a CAGR above 4.6% across 2026-2035. The industry’s...
Need an Industry Research study we haven't published yet?
Our Healthcare team scopes custom studies using the same interview network and validation framework — typically delivered in 2–3 weeks.